Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SNS Financial Group LLC trimmed its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the 2nd quarter, Holdings Channel reports. The firm owned 5,547 shares of the biopharmaceutical company’s stock after selling 278 shares during the period. SNS Financial Group LLC’s holdings in Bristol-Myers Squibb were worth $355,000 as of […]
Smallwood Wealth Investment Management LLC lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.3% in the second quarter, Holdings Channel reports. The firm owned 7,184 shares of the biopharmaceutical company’s stock after selling 172 shares during the period. Smallwood Wealth Investment Management LLC’s holdings in Bristol-Myers Squibb were worth $459,000 […]
GPS Wealth Strategies Group LLC decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,076 shares of the biopharmaceutical company’s stock after selling 514 shares during […]
Guardian Investment Management lessened its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.6% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 35,668 shares of the biopharmaceutical company’s stock after selling 9,278 shares during the period. Bristol-Myers Squibb accounts for about 2.0% of Guardian Investment Management’s holdings, making the stock its […]
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lifted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 144.9% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 35,601 shares of the biopharmaceutical company’s stock after buying an additional 21,065 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in Bristol-Myers Squibb were worth […]